SCHEMBL7065388

SCHEMBL7065388

Cc1ccc(S(=O)(=O)ON(N=Cc2cc(F)cc(F)c2)C(=N)N)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.38
GFER P55789 1/20 0.36
KMT2A Q03164 8/20 0.36
MEN1 O00255 7/20 0.36
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
LMNA P02545 4/20 0.36
HTT P42858 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK1 P28482 1/20 0.34
F2 P00734 2/20 0.33
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064635 0.84 GFER (0.38) ATMGFERKMT2AMEN1MAPT
SCHEMBL7065660 0.84 ALDH1A1 (0.39) ATMGFERKMT2AMEN1MAPT
SCHEMBL7062964 0.84 GFER (0.38) ATMGFERKMT2AMEN1MAPT
SCHEMBL7062979 0.84 GFER (0.38) ATMGFERKMT2AMEN1MAPT
SCHEMBL7065198 0.84 ATM (0.45) ATMGFERKMT2AMEN1MAPT
SCHEMBL7062408 0.81 ALDH1A1 (0.39) ATMGFERKMT2AMEN1MAPT
SCHEMBL7062480 0.81 ALDH1A1 (0.47) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL7062984 0.81 MAPT (0.33) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL915932 0.81 PTGS2 (0.47) GFERKMT2AMEN1MAPTALDH1A1
SCHEMBL7066010 0.80 GRIN2D (0.41) ATMKMT2AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed